Cleared Traditional

K051607 - NOVASPINE CEMENT RESTRICTOR NSCR

K051607 is an FDA 510(k) clearance for NOVASPINE CEMENT RESTRICTOR NSCR, manufactured by Novaspine, LLC. The device is a Class 2 Orthopedic device with product code JDK cleared through the Traditional 510(k) pathway after a 112-day FDA review.

K051607 · Novaspine, LLC · Orthopedic device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2005
Decision
112d
Days
Class 2
Risk

K051607 is an FDA 510(k) clearance for the NOVASPINE CEMENT RESTRICTOR NSCR. Classified as Prosthesis, Hip, Cement Restrictor (product code JDK), Class II - Special Controls.

Submitted by Novaspine, LLC (Elmsford, US). The FDA issued a Cleared decision on October 7, 2005 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 878.3300 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K051607

510(k) Number K051607 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 17, 2005
Decision Date October 07, 2005
Days to Decision 112 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d faster than avg
Panel avg: 122d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JDK Device Classification - Class 2, Special Controls

Product Code JDK Prosthesis, Hip, Cement Restrictor
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - JDK Prosthesis, Hip, Cement Restrictor

All 52
Devices cleared under the same product code (JDK) and FDA review panel - the closest regulatory comparables to K051607.
SPINAL USA CEMENT RESTRICTOR SYSTEM
K060132 · Spinal USA · Mar 2006
INTERBODY INNOVATIONS CEMENT RESTRICTOR
K051371 · Interbody Innovations, Llp · Dec 2005
SKELITE RESORBABLE CEMENT RESTRICTOR
K051836 · Millenium Biologix, Inc. · Nov 2005
SCIENT'X CEMENT RESTRICTOR
K052367 · Scient'X · Oct 2005
POLYGRAFT BGS
K041382 · Osteobiologics, Inc. · Jun 2005
MODIFICATION TO: VENTED CEMENT RESTRICTOR, MODEL 60102-000-001/004
K050699 · Amedica Corp. · Apr 2005
K051607 · NOVASPINE CEMENT RESTRICTOR NSCR
Download PDF FDA Summary Novaspine, LLC